Skip to content Skip to sidebar Skip to footer
MTM
Metallium (ASX:MTM): From 900% Growth to U.S. Policy Tailwinds – What’s Next?
Metallium (ASX: MTM): Chasing a Rare Earths Breakthrough Metallium Limited (ASX: MTM) sits at the center of one of the most pressing issues in global markets today. Rare earth elements are critical to everything from electric vehicles to defense systems, yet nearly 90 percent of processing remains concentrated in China. That control gives Beijing extraordinary pricing…
Objective
Objective’s Results Spark 19% Gains, but Is the Growth Just Beginning?
Objective Hits Record Highs as Recurring Revenue Powers Growth Objective Corporation (ASX:OCL) gave investors plenty to celebrate after its 2025 full-year results sent the stock up 19 percent to fresh all-time highs. For patient shareholders, the rally capped an impressive 80 percent return over the past year. The company has been steadily reshaping itself into…
Telix
Is the Market Missing Telix’s Long-Term Potential after 63% Revenue Growth?
Telix Pharmaceuticals: Controversy, Growth, and the Road Ahead Every investor knows the uneasy feeling of watching a stock fall, not because of poor earnings, but because of controversy. That is the position Telix Pharmaceuticals (ASX: TLX) finds itself in today. After headlines about an FDA subpoena related to how it communicated drug progress to investors,…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here